Cargando…
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
BACKGROUND: Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) reduces hospitalizations among outpatients treated early after symptom onset. It is unknown whether CCP reduces time to symptom resolution among outpatients. METHODS: We evaluated symptom resolution at day 14 by trial arm usin...
Autores principales: | Baksh, Sheriza N, Heath, Sonya L, Fukuta, Yuriko, Shade, David, Meisenberg, Barry, Bloch, Evan M, Tobian, Aaron A R, Spivak, Emily S, Patel, Bela, Gerber, Jonathan, Raval, Jay S, Forthal, Donald, Paxton, James, Mosnaim, Giselle, Anjan, Shweta, Blair, Janis, Cachay, Edward, Currier, Judith, Das, Piyali, Huaman, Moises, Sutcliffe, Catherine, Yarava, Anusha, Casadevall, Arturo, Sullivan, David, Hanley, Daniel, Gebo, Kelly A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226658/ https://www.ncbi.nlm.nih.gov/pubmed/36722044 http://dx.doi.org/10.1093/infdis/jiad023 |
Ejemplares similares
-
401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy
por: Fukuta, Yuriko, et al.
Publicado: (2023) -
Early Treatment, Inflammation and Post-COVID Conditions
por: Gebo, Kelly A., et al.
Publicado: (2023) -
Early antibody treatment, inflammation, and risk of post-COVID conditions
por: Gebo, Kelly A., et al.
Publicado: (2023) -
How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?
por: Bloch, Evan M., et al.
Publicado: (2022) -
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
por: Sullivan, David J., et al.
Publicado: (2022)